All You Need To Know About The German Marijuana Market: Changes, Size And Leading Players

Senior analyst Pablo Zuanic of Zuanic & Associates outlines the transformative potential of new legislation in Germany’s medical cannabis sector, forecasting market growth from a 28,000 patient base in 2023 to a value of €1.7 billion by 2025.

Zuanic emphasizes the nuanced reality behind Germany’s cannabis “legalization,” a gradual, phased approach to full legalization.

The initial phase allows for the possession, home cultivation and social clubs, though retail sales remain off-limits, posing potential risks and benefits.

A speculative second phase could introduce sales in select areas. Now, a question for investors arises: what drives this anticipated surge in Germany’s medical marijuana market and how will the number of cash-paying medical marijuana users change?

Key Beneficiaries In the Surge

Zuanic‘s projections hinge on the assumption that 1% of Germany’s roughly 85 million people will become medical marijuana cash payers, a stark increase from the current 0.03%.

He points to easier access and lower prices, facilitated by online clinics and pharmacies, alongside the new regulatory landscape, as key drivers of this growth.

“Medical cannabis was already federally legal …

Full story available on Benzinga.com